Matulonis UA, Shapira-Frommer R, Santin AD, Lisyanskaya AS, et al. Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study. Ann Oncol 2019;30:1080-1087.
PMID: 31987374